BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29230007)

  • 1. Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy.
    Özsoy M; Moschini M; Fajkovic H; Soria F; Seitz C; Klatte T; Gust K; Briganti A; Karakiewicz PI; Roupret M; Kramer G; Shariat SF
    Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):100-105. PubMed ID: 29230007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
    Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
    Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High preoperative neutrophil-lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy.
    Lee H; Jeong SJ; Hong SK; Byun SS; Lee SE; Oh JJ
    World J Urol; 2016 Jun; 34(6):821-7. PubMed ID: 26449784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6.
    Wang H; Gu L; Wu Y; Feng D; Duan J; Wang X; Huang Y; Wu S; Chen J; Luo G; Zhang X
    BMC Cancer; 2017 Sep; 17(1):629. PubMed ID: 28874127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer.
    Jang WS; Cho KS; Kim KH; Yoon CY; Kang YJ; Lee JY; Ham WS; Rha KH; Hong SJ; Choi YD
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):298-304. PubMed ID: 27349499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy.
    Cao Z; Ji J; Zhang C; Wang F; Xu H; Yu Y; Sun Y
    Cancer Med; 2019 Mar; 8(3):1004-1012. PubMed ID: 30693666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.
    Ferro M; Musi G; Serino A; Cozzi G; Mistretta FA; Costa B; Bianchi R; Cordima G; Luzzago S; Di Trapani E; Tagliabue E; Vartolomei MD; Terracciano D; Cassatella MC; Salvatici M; Conti A; Sandri MT; Cioffi A; Turetti M; Catellani M; Bottero D; Matei DV; Mirone V; de Cobelli O
    Urol Int; 2019; 102(1):43-50. PubMed ID: 30408799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
    Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
    Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of neutrophil-to-lymphocyte ratio as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy.
    Lu Y; Huang HH; Lau WKO
    World J Urol; 2020 Jan; 38(1):103-109. PubMed ID: 30953141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is neutrophile to lymphocyte ratio a predictor of Gleason score upgrading according to risk classifications in patients with prostate cancer.
    Karadağ S; Ekşi M; Özdemir O; Akkaş F; Arikan Y; Özlü DN; Çolakoğlu Y; Aliş D; Şahin S; Tuğcu V
    Arch Esp Urol; 2021 Jul; 74(6):599-605. PubMed ID: 34219063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer.
    Léon P; Seisen T; Cussenot O; Drouin SJ; Cattarino S; Compérat E; Renard-Penna R; Mozer P; Bitker MO; Rouprêt M
    Urol Oncol; 2015 Sep; 33(9):384.e21-7. PubMed ID: 25595576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.
    Wettstein MS; Saba K; Umbehr MH; Murtola TJ; Fankhauser CD; Adank JP; Hofmann M; Sulser T; Hermanns T; Moch H; Wild P; Poyet C
    Prostate; 2017 Apr; 77(5):549-556. PubMed ID: 28093792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of neutrophil-to-lymphocyte and platelets-to-lymphocyte ratio in predicting biochemical recurrence post robotic prostatectomy.
    Zanaty M; Ajib K; Alnazari M; El Rassy E; Aoun F; Zorn KC; El-Hakim A
    Biomark Med; 2018 Aug; 12(8):841-848. PubMed ID: 30019909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy.
    Maeda Y; Kawahara T; Koizumi M; Ito H; Kumano Y; Ohtaka M; Kondo T; Mochizuki T; Hattori Y; Teranishi J; Yumura Y; Miyoshi Y; Yao M; Miyamoto H; Uemura H
    Biomed Res Int; 2016; 2016():6197353. PubMed ID: 27200375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of inflammatory factors in prediction of Gleason score and its upgrading in localized prostate cancer patients after radical prostatectomy.
    Wang S; Ji Y; Ma J; Du P; Cao Y; Yang X; Yu Z; Yang Y
    Front Oncol; 2022; 12():1079622. PubMed ID: 36713540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.
    Gao Y; Jiang CY; Mao SK; Cui D; Hao KY; Zhao W; Jiang Q; Ruan Y; Xia SJ; Han BM
    Asian J Androl; 2016; 18(4):639-43. PubMed ID: 26732103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy.
    Wang S; Yang X; Yu Z; Du P; Sheng X; Cao Y; Yan X; Ma J; Yang Y
    Front Oncol; 2022; 12():907625. PubMed ID: 35719913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy.
    Sevcenco S; Mathieu R; Baltzer P; Klatte T; Fajkovic H; Seitz C; Karakiewicz PI; Rouprêt M; Rink M; Kluth L; Trinh QD; Loidl W; Briganti A; Scherr DS; Shariat SF
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):163-7. PubMed ID: 26810014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we use neutrophil to lymphocyte ratio in the diagnosis and prediction of extracapsular extension in localized prostate cancer?
    Merder E; Arıman A; Dinçer S; Altunrende F
    Urologia; 2022 May; 89(2):203-209. PubMed ID: 33960239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.